Cargando…
Histone Deacetylase Inhibition Regulates Lipid Homeostasis in a Mouse Model of Amyotrophic Lateral Sclerosis
Amyotrophic lateral sclerosis (ALS) is an incurable and fatal neurodegenerative disorder of the motor system. While the etiology is still incompletely understood, defects in metabolism act as a major contributor to the disease progression. Recently, histone deacetylase (HDAC) inhibition using ACY-73...
Autores principales: | Burg, Thibaut, Rossaert, Elisabeth, Moisse, Matthieu, Van Damme, Philip, Van Den Bosch, Ludo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8541517/ https://www.ncbi.nlm.nih.gov/pubmed/34681883 http://dx.doi.org/10.3390/ijms222011224 |
Ejemplares similares
-
Opportunities for histone deacetylase inhibition in amyotrophic lateral sclerosis
por: Klingl, Yvonne E., et al.
Publicado: (2020) -
Modelling amyotrophic lateral sclerosis: progress and possibilities
por: Van Damme, Philip, et al.
Publicado: (2017) -
Restoration of histone acetylation ameliorates disease and metabolic abnormalities in a FUS mouse model
por: Rossaert, Elisabeth, et al.
Publicado: (2019) -
Therapeutic potential of HDAC6 in amyotrophic lateral sclerosis
por: Guo, Wenting, et al.
Publicado: (2017) -
The Role of Nucleocytoplasmic Transport Defects in Amyotrophic Lateral Sclerosis
por: Vanneste, Joni, et al.
Publicado: (2021)